<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Intercept Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Intercept Pharmaceuticals, Inc.

    Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Mark Pruzanski, M.D.
    • FOUNDED
      2002
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Myriad Genetics, Inc.

    Myriad Genetics, Inc.

    Myriad Genetics, Inc., is a leading precision medicine company dedicated to being ...

    Myriad Genetics, Inc., is a leading precision m...

    Filing Type:    PU
    Incyte Corporation

    Incyte Corporation

    Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focus...

    Incyte Corporation is a Wilmington, Delaware-ba...

    Filing Type:    PU
    TherapeuticsMD, Inc.

    TherapeuticsMD, Inc.

    TherapeuticsMD, Inc. is an innovative pharmaceutical company exclusively committed...

    TherapeuticsMD, Inc. is an innovative pharmaceu...

    Filing Type:    PU
    Gilead Sciences, Inc.

    Gilead Sciences, Inc.

    Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers...

    Gilead Sciences, Inc. is a research-based bioph...

    Filing Type:    PU
    Takeda Pharmaceutical Co., Ltd.

    Takeda Pharmaceutical Co., Ltd.

    Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-base...

    Takeda Pharmaceutical Company Limited (TSE:4502...

    Filing Type:    PU
    Reliv International, Inc.

    Reliv International, Inc.

    Reliv International, based in Chesterfield, MO, produces nutritional supplements t...

    Reliv International, based in Chesterfield, MO,...

    Filing Type:    PU
    Cara Therapeutics, Inc.

    Cara Therapeutics, Inc.

    Cara Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Cara Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    Albireo Pharma, Inc.

    Albireo Pharma, Inc.

    Albireo is a clinical-stage biopharmaceutical company focused on the development a...

    Albireo is a clinical-stage biopharmaceutical c...

    Filing Type:    PU
    GENFIT S.A.

    GENFIT S.A.

    GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and de...

    GENFIT is a late-stage biopharmaceutical compan...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.